Longevity Health Holdings, Inc. Proceeds from Sale of Restricted Investments
Longevity Health Holdings, Inc. (XAGE) reported Proceeds from Sale of Restricted Investments of $0 for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow
us-gaap:ProceedsFromSaleOfRestrictedInvestments · last filed 2023-08-14
- Longevity Health Holdings, Inc. proceeds from sale of restricted investments for the quarter ending 2023-06-30 was $0.00.
- Longevity Health Holdings, Inc. proceeds from sale of restricted investments for the quarter ending 2023-03-31 was $0.00.
| Period end | Proceeds from Sale of Restricted Investments 3 month | Proceeds from Sale of Restricted Investments 6 month |
|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |